Illumina在华遇挫,基因组学巨头股价折价——Finimize
Illumina’s China Setback Leaves A Discounted Genomics Leader - Finimize
生物技术与制药领域的最新动态
Illumina’s China Setback Leaves A Discounted Genomics Leader - Finimize
Will Illumina Inc. stock outperform international peers - Trade Risk Report & Free Fast Entry Momentum Trade Alerts - moha.gov.vn
Is Illumina Inc. stock undervalued vs historical averages - Trend Reversal & Fast Moving Trade Plans - BỘ NỘI VỤ
When a worldwide community comes together - Illumina
Illumina price attacks important resistance - Forecast today - 26-11-2025 - Economies.com
Illumina Completes $500M Notes Offering for Expansion - TipRanks
How Will Analyst Reactions to ILMN’s Wolfe Conference Pitch Shape Confidence in Its Turnaround Plan? - simplywall.st
Illumina CEO Jacob Thaysen: Anchoring “In China, For China” to Drive a New Chapter in China’s Healthcare Through Technology - Caixin Global
Illumina (ILMN): A Fresh Look at Valuation as Protein Prep Gains Ground in Global Research Labs - simplywall.st
Illumina, Inc. Stock (ILMN) Opinions on Strategic Growth and Market Expansion - Quiver Quantitative
The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know - MSN
3 Reasons to Sell ILMN and 1 Stock to Buy Instead - Finviz
Tackling antimicrobial resistance, one genome at a time - Illumina